Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH.

Wasson CW, Abignano G, Hermes H, Malaab M, Ross RL, Jimenez SA, Chang HY, Feghali-Bostwick CA, Del Galdo F.

Ann Rheum Dis. 2020 Apr;79(4):507-517. doi: 10.1136/annrheumdis-2019-216542. Epub 2020 Feb 10.

2.

Implementing Risk Stratification in Primary Care: Challenges and Strategies.

Wagner J, Hall JD, Ross RL, Cameron D, Sachdeva B, Kansagara D, Cohen DJ, Dorr DA.

J Am Board Fam Med. 2019 Jul-Aug;32(4):585-595. doi: 10.3122/jabfm.2019.04.180341.

3.

Metabolic control of BRISC-SHMT2 assembly regulates immune signalling.

Walden M, Tian L, Ross RL, Sykora UM, Byrne DP, Hesketh EL, Masandi SK, Cassel J, George R, Ault JR, El Oualid F, Pawłowski K, Salvino JM, Eyers PA, Ranson NA, Del Galdo F, Greenberg RA, Zeqiraj E.

Nature. 2019 Jun;570(7760):194-199. doi: 10.1038/s41586-019-1232-1. Epub 2019 May 29.

4.

Defining High Value Elements for Reducing Cost and Utilization in Patient-Centered Medical Homes for the TOPMED Trial.

Anastas TM, Wagner J, Ross RL, Sachdeva B, Michaels L, Gray K, Cartwright K, Dorr DA.

EGEMS (Wash DC). 2019 May 3;7(1):20. doi: 10.5334/egems.246.

5.

Detection of ribonucleoside modifications by liquid chromatography coupled with mass spectrometry.

Jora M, Lobue PA, Ross RL, Williams B, Addepalli B.

Biochim Biophys Acta Gene Regul Mech. 2019 Mar;1862(3):280-290. doi: 10.1016/j.bbagrm.2018.10.012. Epub 2018 Nov 7. Review.

6.

Nano LC-MS using capillary columns enables accurate quantification of modified ribonucleosides at low femtomol levels.

Sarin LP, Kienast SD, Leufken J, Ross RL, Dziergowska A, Debiec K, Sochacka E, Limbach PA, Fufezan C, Drexler HCA, Leidel SA.

RNA. 2018 Oct;24(10):1403-1417. doi: 10.1261/rna.065482.117. Epub 2018 Jul 16.

7.

Evolutionary insights into Trm112-methyltransferase holoenzymes involved in translation between archaea and eukaryotes.

van Tran N, Muller L, Ross RL, Lestini R, Létoquart J, Ulryck N, Limbach PA, de Crécy-Lagard V, Cianférani S, Graille M.

Nucleic Acids Res. 2018 Sep 19;46(16):8483-8499. doi: 10.1093/nar/gky638.

8.

Differentiating Positional Isomers of Nucleoside Modifications by Higher-Energy Collisional Dissociation Mass Spectrometry (HCD MS).

Jora M, Burns AP, Ross RL, Lobue PA, Zhao R, Palumbo CM, Beal PA, Addepalli B, Limbach PA.

J Am Soc Mass Spectrom. 2018 Aug;29(8):1745-1756. doi: 10.1007/s13361-018-1999-6. Epub 2018 Jun 12.

9.

Lactulose as a novel template for anticancer drug development targeting galectins.

Kishor C, Ross RL, Blanchard H.

Chem Biol Drug Des. 2018 Oct;92(4):1801-1808. doi: 10.1111/cbdd.13348. Epub 2018 Jul 1.

PMID:
29888844
10.

Specifications of Clinical Quality Measures and Value Set Vocabularies Shift Over Time: A Study of Change through Implementation Differences.

Cholan RA, Weiskopf NG, Rhoton DL, Colin NV, Ross RL, Marzullo MN, Sachdeva B, Dorr DA.

AMIA Annu Symp Proc. 2018 Apr 16;2017:575-584. eCollection 2017.

11.

Patient-derived mutations within the N-terminal domains of p85α impact PTEN or Rab5 binding and regulation.

Mellor P, Marshall JDS, Ruan X, Whitecross DE, Ross RL, Knowles MA, Moore SA, Anderson DH.

Sci Rep. 2018 May 8;8(1):7108. doi: 10.1038/s41598-018-25487-5.

12.

Transforming Growth Factor β Activation Primes Canonical Wnt Signaling Through Down-Regulation of Axin-2.

Gillespie J, Ross RL, Corinaldesi C, Esteves F, Derrett-Smith E, McDermott MF, Doody GM, Denton CP, Emery P, Del Galdo F.

Arthritis Rheumatol. 2018 Jun;70(6):932-942. doi: 10.1002/art.40437. Epub 2018 Apr 23.

13.

Human papillomavirus type 18 E5 oncogene supports cell cycle progression and impairs epithelial differentiation by modulating growth factor receptor signalling during the virus life cycle.

Wasson CW, Morgan EL, Müller M, Ross RL, Hartley M, Roberts S, Macdonald A.

Oncotarget. 2017 Oct 6;8(61):103581-103600. doi: 10.18632/oncotarget.21658. eCollection 2017 Nov 28.

14.

Perceptions of Risk Stratification Workflows in Primary Care.

Ross RL, Sachdeva B, Wagner J, Ramsey K, Dorr DA.

Healthcare (Basel). 2017 Oct 21;5(4). pii: E78. doi: 10.3390/healthcare5040078.

15.
16.

PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma.

Ross RL, McPherson HR, Kettlewell L, Shnyder SD, Hurst CD, Alder O, Knowles MA.

BMC Cancer. 2016 Jul 28;16:553. doi: 10.1186/s12885-016-2570-0.

17.

Induction based fluidics (IBF) for droplet-based mass spectrometric analysis of oligonucleotides.

Ross RL, Sauter AD Jr, Limbach PA.

J Mass Spectrom. 2015 Oct;50(10):1175-9. doi: 10.1002/jms.3636.

PMID:
26456787
18.

Fibrinogen and catheter-directed thrombolysis.

Ross RL, Beck AW.

Semin Vasc Surg. 2014 Dec;27(3-4):182-95. doi: 10.1053/j.semvascsurg.2015.04.003. Epub 2015 Apr 6. Review.

PMID:
26073829
19.

Preliminary evidence of a blunted anti-inflammatory response to exhaustive exercise in fibromyalgia.

Torgrimson-Ojerio B, Ross RL, Dieckmann NF, Avery S, Bennett RM, Jones KD, Guarino AJ, Wood LJ.

J Neuroimmunol. 2014 Dec 15;277(1-2):160-7. doi: 10.1016/j.jneuroim.2014.10.003. Epub 2014 Oct 18.

20.

Identification of mutations in distinct regions of p85 alpha in urothelial cancer.

Ross RL, Burns JE, Taylor CF, Mellor P, Anderson DH, Knowles MA.

PLoS One. 2013 Dec 18;8(12):e84411. doi: 10.1371/journal.pone.0084411. eCollection 2013.

21.

Prophylactic platelet transfusions.

Pietersz RN, Reesink HW, Panzer S, Gilbertson MP, Borosak ME, Wood EM, Leitner GC, Rabitsch W, Ay C, Lambermont M, Deneys V, Sondag D, Compernolle V, Legrand D, François A, Tardivel R, Garban F, Sawant RB, Rebulla P, Handa M, Ohto H, Kerkhoffs JL, Brand A, Zhiburt E, Cid J, Escolar G, Lozano M, Puig L, Knutson F, Hallböök H, Lubenow N, Estcourt L, Stanworth S, Murphy MF, Williams L, Mraz DL, Ross RL, Snyder E.

Vox Sang. 2012 Aug;103(2):159-76. doi: 10.1111/j.1423-0410.2012.01595.x. Epub 2012 Apr 20. No abstract available.

PMID:
22519879
22.

PIK3CA mutation spectrum in urothelial carcinoma reflects cell context-dependent signaling and phenotypic outputs.

Ross RL, Askham JM, Knowles MA.

Oncogene. 2013 Feb 7;32(6):768-76. doi: 10.1038/onc.2012.87. Epub 2012 Mar 19.

PMID:
22430209
23.

Duloxetine for the treatment of fibromyalgia.

Wright CL, Mist SD, Ross RL, Jones KD.

Expert Rev Clin Immunol. 2010 Sep;6(5):745-56. doi: 10.1586/eci.10.64. Review.

24.

Atypical depression is more common than melancholic in fibromyalgia: an observational cohort study.

Ross RL, Jones KD, Ward RL, Wood LJ, Bennett RM.

BMC Musculoskelet Disord. 2010 Jun 14;11:120. doi: 10.1186/1471-2474-11-120.

25.
26.

Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer.

Knowles MA, Platt FM, Ross RL, Hurst CD.

Cancer Metastasis Rev. 2009 Dec;28(3-4):305-16. doi: 10.1007/s10555-009-9198-3. Review.

27.

The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties.

Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL.

Arthritis Res Ther. 2009;11(4):R120. doi: 10.1186/ar2783. Epub 2009 Aug 10. Erratum in: Arthritis Res Ther. 2009;11(5):415.

28.

Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.

Ross RL, Serock MR, Khalil RA.

Curr Cardiol Rev. 2008 Nov;4(4):309-22. doi: 10.2174/157340308786349462.

29.

Management of blood shortages in a tertiary care academic medical center: the Yale-New Haven Hospital frozen blood reserve.

Erickson ML, Champion MH, Klein R, Ross RL, Neal ZM, Snyder EL.

Transfusion. 2008 Oct;48(10):2252-63. doi: 10.1111/j.1537-2995.2008.01816.x. Epub 2008 Jul 8. Review.

PMID:
18631164
30.

Effect of dietary sodium on vasoconstriction and eNOS-mediated vascular relaxation in caveolin-1-deficient mice.

Pojoga LH, Yao TM, Sinha S, Ross RL, Lin JC, Raffetto JD, Adler GK, Williams GH, Khalil RA.

Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1258-65. doi: 10.1152/ajpheart.01014.2007. Epub 2008 Jan 4.

31.

Antidepressant treatment for fibromyalgia. Avoiding two dangerous syndromes.

Ross RL, Adams DG, Jones KD.

Adv Nurse Pract. 2007 Jun;15(6):45-6, 51-4. No abstract available.

PMID:
19999009
33.

The genome of deep-sea vent chemolithoautotroph Thiomicrospira crunogena XCL-2.

Scott KM, Sievert SM, Abril FN, Ball LA, Barrett CJ, Blake RA, Boller AJ, Chain PS, Clark JA, Davis CR, Detter C, Do KF, Dobrinski KP, Faza BI, Fitzpatrick KA, Freyermuth SK, Harmer TL, Hauser LJ, Hügler M, Kerfeld CA, Klotz MG, Kong WW, Land M, Lapidus A, Larimer FW, Longo DL, Lucas S, Malfatti SA, Massey SE, Martin DD, McCuddin Z, Meyer F, Moore JL, Ocampo LH Jr, Paul JH, Paulsen IT, Reep DK, Ren Q, Ross RL, Sato PY, Thomas P, Tinkham LE, Zeruth GT.

PLoS Biol. 2006 Nov;4(12):e383.

34.

Validity of the Depression-Arkansas (D-ARK) Scale: a tool for measuring major depressive disorder.

Smith GR, Kramer TL, Hollenberg JA, Mosley CL, Ross RL, Burnam A.

Ment Health Serv Res. 2002 Sep;4(3):167-73.

PMID:
12385569
35.

Rural and urban problem drinkers in six Southern states.

Booth BM, Ross RL, Rost K.

Subst Use Misuse. 1999 Mar-Apr;34(4-5):471-93.

PMID:
10210089
36.

Does this treatment work? Validation of an outcomes module for alcohol dependence.

Rost KM, Ross RL, Humphrey J, Frank S, Smith J, Smith GR.

Med Care. 1996 Apr;34(4):283-94.

PMID:
8606554
37.

Utilization of acute inpatient services for alcohol detoxification.

Booth BM, Blow FC, Ludke RL, Ross RL.

J Ment Health Adm. 1996 Fall;23(4):366-74.

PMID:
8965052
38.

Women's health.

Ross RL.

N Engl J Med. 1993 Dec 9;329(24):1816-7. No abstract available.

PMID:
8232496
39.

The Americans with Disabilities Act.

Ross RL 3rd, Seiter PD, McDowell WJ.

Ala Med. 1992 Sep;62(3):23-6. No abstract available.

PMID:
1442458
40.

Psychiatrists' compliance with nonpsychiatric consultations: does compliance affect concordance?

Malhotra N, Ross RL, Epstein S, Mann LS, Wise TN.

Int J Psychiatry Med. 1991;21(2):119-26.

PMID:
1894451
41.

Neurosyphilis and organic mood syndrome: a forgotten diagnosis.

Ross RL, Smith GR Jr, Guggenheim FG.

Psychosomatics. 1990 Fall;31(4):448-50. No abstract available.

PMID:
2247575
42.

Chewing and spitting associated with a protein sparing modified fast and psychosocial stressors.

Smith GR Jr, Ross RL.

Psychosomatics. 1989 Spring;30(2):224-6. No abstract available.

PMID:
2710922
43.

Rapid assay for heparin during extracorporeal circulation.

Ross RL, Whittlesey GC, Splittgerber FH, Salley SO, Klein MD.

ASAIO Trans. 1986 Jul-Sep;32(1):274-7. No abstract available.

PMID:
2430602
44.

Solvent systems for intracarotid 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) infusion.

Ross RL, Kapp JP, Hochberg F, Krull IS, Ding XD, Selavka C.

Neurosurgery. 1983 May;12(5):512-4.

PMID:
6866232
45.

Supraophthalmic carotid infusion for brain-tumor chemotherapy. Technical note.

Kapp JP, Ross RL, Tucker EM.

J Neurosurg. 1983 Apr;58(4):616-8.

PMID:
6827360
46.

A drug abuse rehabilitation program.

Hilker RR, Asma FE, Daghestani AN, Ross RL.

J Occup Med. 1975 Jun;17(6):351-4. No abstract available.

PMID:
1159543
47.

Exposure in abdominal surgery.

ROSS RL.

Northwest Med. 1958 Jan;57(1):36. No abstract available.

PMID:
13493875
48.
49.

Recurrent varicose veins.

ROSS RL.

Calif Med. 1957 Sep;87(3):168-70.

Supplemental Content

Support Center